Allspring Global Investments’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,676
Closed -$165K 1947
2024
Q3
$165K Sell
5,676
-421
-7% -$10.4K ﹤0.01% 1711
2024
Q2
$142K Sell
6,097
-63
-1% -$1.21K ﹤0.01% 1786
2024
Q1
$126K Buy
6,160
+519
+9% +$9.75K ﹤0.01% 1799
2023
Q4
$121K Buy
5,641
+475
+9% +$9.41K ﹤0.01% 1774
2023
Q3
$107K Sell
5,166
-327
-6% -$8.29K ﹤0.01% 1975
2023
Q2
$162K Sell
5,493
-115
-2% -$3.23K ﹤0.01% 1877
2023
Q1
$129K Buy
5,608
+2,366
+73% +$65.1K ﹤0.01% 1952
2022
Q4
$90.2K Sell
3,242
-71
-2% -$2.11K ﹤0.01% 2113
2022
Q3
$101K Buy
3,313
+1,005
+44% +$32.7K ﹤0.01% 2083
2022
Q2
$67K Sell
2,308
-37,909
-94% -$993K ﹤0.01% 2169
2022
Q1
$1.29M Buy
40,217
+1,605
+4% +$55.2K ﹤0.01% 1737
2021
Q4
$1.72M Buy
+38,612
New +$1.83M ﹤0.01% 1621

Other funds holding DNLI